Clinical Trials

32 enrolled 23 charts

Breast Neoplasms

NCT02514681 2025-09-10

PRECIOUS

226 enrolled

Breast Neoplasms

NCT01815242 2025-02-27

ADAPT

336 enrolled

Breast Neoplasms

NCT01822314 2024-03-07

ETNA

632 enrolled

Breast Neoplasms, Neoplasms

NCT00618657 2024-02-28

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

127 enrolled 12 charts

Breast Neoplasms

NCT04247126 2023-10-27

A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors

BreastGastrointestinalThoracic

105 enrolled

Breast Neoplasms, Pancreatic Neoplasms, Small Cell Lung Carcinoma

NCT02915744 2023-04-14

ATTAIN

178 enrolled 37 charts

Breast Neoplasms, Carcinoma, Neoplasm Metastasis

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

47 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01565499 2023-03-30

Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer

83 enrolled 24 charts

Breast Neoplasms

NCT04132817 2022-12-02

A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread

12 enrolled

Breast Neoplasms

NCT05609903 2022-11-08

Anastase

Completed

52 enrolled

Breast Neoplasms

NCT00785291 2022-10-10

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

799 enrolled 18 charts

Breast Neoplasms

NCT02379247 2022-06-07

BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

Phase 1/2 Completed

43 enrolled 18 charts

Breast Neoplasms

NCT03166085 2021-12-20

PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer

12 enrolled

Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

10 enrolled 12 charts

Breast Neoplasms

NCT03289819 2021-04-08

NIB

53 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02685059 2021-02-15

GeparNuevo

174 enrolled

Breast Neoplasms

NCT01690702 2021-02-02

GAIN-2

2,886 enrolled

Breast Neoplasms

NCT02632071 2021-01-07

ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer

17 enrolled

Breast Neoplasms

NCT01572038 2020-09-25

PERUSE

1,436 enrolled 53 charts

Breast Neoplasms

NCT01803282 2020-06-02

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

BreastGastrointestinalThoracic

236 enrolled 21 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00394082 2019-11-25

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

50 enrolled 17 charts

Breast Neoplasms

NCT02309177 2019-05-31

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

BreastGastrointestinalThoracic

114 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT02073916 2019-04-16

STELA

24 enrolled

Breast Neoplasms

NCT00254592 2019-02-28

Neoadjuvant Treatment of Breast Cancer

43 enrolled 7 charts

Breast Neoplasms

NCT01881230 2019-02-21

tnAcity

Phase 2/3 Completed

191 enrolled 22 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00733408 2018-12-04

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

59 enrolled 14 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02019277 2018-09-13

SAPPHIRE

50 enrolled 18 charts

Breast Neoplasms

NCT01493310 2018-09-12

Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

9 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

32 enrolled 7 charts

Breast Neoplasms

NCT02783222 2018-01-10

EFFECT

160 enrolled

Breast Neoplasms

NCT00821964 2018-01-02

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

15 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00407888 2017-08-31

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

60 enrolled 11 charts

Breast Neoplasms

NCT00748553 2017-07-26

VA

Phase 1/2 Completed

30 enrolled 7 charts

Breast Neoplasms

NCT02555696 2017-02-23

Abraxane in Treatment of Metastatic Breast Cancer

Completed

203 enrolled

Breast Neoplasms

NCT01763710 2016-03-29

neurabrax

60 enrolled

Breast Neoplasms, Neurotoxicity Syndromes

NCT02064829 2016-03-25

TRIBECA

Phase NA Completed

111 enrolled

Breast Neoplasms

NCT01204437 2016-02-10

ICE-II

Phase 2/3 Completed

400 enrolled

Breast Neoplasms

NCT01432223 2015-04-22

Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab

46 enrolled

Breast Neoplasms

NCT00392392 2013-09-20

Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer

29 enrolled 5 charts

Breast Neoplasms

NCT00983424 2013-09-16

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

14 enrolled